# Syngene International Limited (SYNGENE)

> SYNGENE closed at ₹402.70 on 30 Oct 2026, trailing P/E 87.4, market cap ₹16,257 cr, latest results for the quarter ended 30 Sept 2026. Revenue, profit, ROE, debt, own P/E range and sector-peer comparison from the SEBI filing.

Syngene International Limited (NSE: SYNGENE) closed at ₹402.70 on 30 Oct 2026, -36.9% over one year, against a 52-week range of ₹344.45 – ₹678.95.

In the quarter ended 30 Sept 2026 (consolidated, filed 27 Oct 2026) it reported revenue of ₹833 cr and net profit of ₹32 cr, a 3.9% net margin; revenue fell 8.6% and profit fell 44.8% year on year.

On four consecutive filed quarters its trailing P/E is 87.4; since 24 Apr 2025 its own P/E has ranged from 44.5 to 87.0 (median 52.9), and today's reading is higher than 100% of those 375 trading days.

From the balance sheet dated 30 Sept 2026: return on equity 2.7%, ROCE 4.2%, debt-to-equity 0.01, Piotroski F-score 4 of 9.

Against 65 Healthcare peers on NSE: Net margin higher than 13% of 63 sector peers; PBT margin higher than 11% of 63 sector peers; ROE higher than 10% of 63 sector peers.

## Key figures

| Figure | Value |
|---|---|
| Last close | ₹402.70 (30 Oct 2026) |
| Change 1 month / 6 months / 1 year | +5.9% / -4.4% / -36.9% |
| 52-week low – high | ₹344.45 – ₹678.95 |
| Market capitalisation | ₹16,257 cr |
| Trailing P/E | 87.4 |
| Price / book | 3.35 |
| EV / EBITDA | 21.8 |
| Earnings yield | 1.1% |
| TTM EPS | ₹4.61 |
| TTM net profit | ₹186 cr |
| Quarter revenue | ₹833 cr |
| Quarter net profit | ₹32 cr |
| Net margin | 3.9% |
| Revenue growth (YoY) | -8.6% |
| Profit growth (YoY) | -44.8% |
| Return on equity | 2.7% |
| ROCE | 4.2% |
| Debt / equity | 0.01 |
| Current ratio | 1.65 |
| Free cash flow | ₹-353 cr |
| Piotroski F-score | 4 / 9 |
| Average daily turnover (50 days) | ₹16.4 cr |

## Questions

### What is the P/E ratio of Syngene International Limited?

Syngene International Limited's trailing P/E is 87.4, using the close of 30 Oct 2026 and earnings over the four filed quarters to 30 Sept 2026. Since 24 Apr 2025 its P/E has ranged 44.5–87.0.

### What were Syngene International Limited's latest quarterly results?

For the quarter ended 30 Sept 2026, Syngene International Limited reported revenue of ₹833 cr and net profit of ₹32 cr (consolidated), filed with the exchange on 27 Oct 2026.

### What is Syngene International Limited's ROE?

Return on equity is 2.7% based on the balance sheet dated 30 Sept 2026.

### Does Syngene International Limited have debt?

Debt-to-equity is 0.01 on the balance sheet dated 30 Sept 2026.

### What is SYNGENE's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, SYNGENE traded between ₹344.45 and ₹678.95.

Sector: [Healthcare](https://trinetra.trade/sectors/healthcare) · Page: https://trinetra.trade/fundamentals/SYNGENE

_TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing._